Bo Wang,MD: Clinical Trials

5 trials sponsored by Bo Wang,MD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 1 recruiting. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Unknown 3

Follow Bo Wang,MD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dual-Channel Near-Infrared Autofluorescence Imaging and AI Analysis to Locate Parathyroid Glands (PTFinder)
PTFinder Dual-Channel NIR Autofluorescence Imaging System, Offline Machine-Learning Algorithm (PTFinder-AI Beta) - Thyroid Neoplasms, Hyperparathyroidism
RecruitingBo Wang,MD1802025-06-012025-06-18
Lidocaine Reduces Muscle Tremor is Beneficial for Intraoperative Recurrent Laryngeal Nerve Monitoring
Lidocaine - Thyroid Cancer, Neck Cancer
Not applicableUnknownBo Wang,MD402018-05-012018-09-18
Study on Application of Suturing Parathyroid Markers in Thyroid Cancer Surgery
The suture marks the location of the parathyroid gland - Thyroid Cancer, Hypoparathyroidism
Not applicableUnknownBo Wang,MD4002018-04-012018-05-02
Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy
used of the Pressure adjustable foot-control method, direct exhaust - Thyroid Cancer, Papillary Thyroid Carcinoma
Not applicableUnknownBo Wang,MD1002018-01-012018-09-18
The Application of Rapid PTH Test Paper in Operation of Hyperparathyroidism
Hyperthyroidism, Thyroidectomy
UnknownBo Wang,MD902018-01-012018-09-18

Conditions studied

Thyroid Neoplasms (4)  ·  Accessory Nerve Injuries (1)  ·  Head and Neck Neoplasms (1)  ·  Hyperparathyroidism (1)  ·  Hypersensitivity (1)  ·  Hyperthyroidism (1)  ·  Hypoparathyroidism (1)  ·  Recurrent Laryngeal Nerve Injuries (1)  ·  Thyroid Cancer, Papillary (1)

Interventions

Lidocaine (1)

Countries

China (5)